Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$118.38 - $210.04 $166,679 - $295,736
1,408 New
1,408 $253,000
Q1 2022

Apr 19, 2022

SELL
$126.46 - $235.05 $438,942 - $815,858
-3,471 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$225.82 - $368.51 $783,821 - $1.28 Million
3,471 New
3,471 $882,000
Q1 2020

May 05, 2020

SELL
$17.78 - $31.58 $1.12 Million - $1.98 Million
-62,729 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$13.93 - $21.28 $873,814 - $1.33 Million
62,729 New
62,729 $1.23 Million
Q3 2019

Nov 20, 2019

SELL
$12.26 - $18.07 $671,198 - $989,278
-54,747 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$13.7 - $28.34 $750,033 - $1.55 Million
54,747 New
54,747 $801,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.